A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)
Clinical trial NCT03606460 · COMPLETED
Trial details
- NCT number
- NCT03606460
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2019-05-31
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.